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Abstract
Purpose In many countries, patients are generally
allowed to have clear ﬂuids until 2–3 h before surgery. In
Japan, long preoperative fasting is still common practice.
To shorten the preoperative fasting period in Japan, we
tested the safety and efﬁcacy of oral rehydration therapy
until 2 h before surgery.
Methods Three hundred low-risk patients scheduled for
morning surgery in six university-afﬁliated hospitals were
randomly assigned to an oral rehydration solution (ORS)
group or to a fasting group. Patients in the ORS group
consumedupto1,000 mlofORScontainingbalancedglucose
and electrolytes: 500 ml between 2100 the night before sur-
gery and the time they woke up the next morning and 500 ml
during the morning of surgery until 2 h before surgery.
Patients in the fasting group started fasting at 2100 the night
before surgery. Primary endpoints were gastric ﬂuid volume
and pH immediately after anesthesia induction. Several
physiological measures of hydration and electrolytes includ-
ing the fractional excretion of sodium (FENa) and the frac-
tionalexcretionofureanitrogen(FEUN)werealsoevaluated.
Results Mean (SD) gastric ﬂuid volume immediately
after anesthesia induction was 15.1 (14.0) ml in the ORS
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DOI 10.1007/s00540-011-1261-xgroup and 17.5 (23.2) ml in the fasting group (P = 0.30).
The mean difference between the ORS group and fasting
group was -2.5 ml. The 95% conﬁdence interval ranged
from -7.1 to ?2.2 ml and did not include the noninferior
limit of ?8 ml. Mean (SD) gastric ﬂuid pH was 2.1 (1.9) in
the ORS group and 2.2 (2.0) in the fasting group
(P = 0.59). In the ORS group, mean FENa and FEUN
immediately after anesthesia induction were both signiﬁ-
cantly greater than those in the fasting group (P\0.001
for both variables). The ORS group reported they had been
less thirsty and hungry before surgery (P\0.001, 0.01).
Conclusions Oral rehydration therapy until 2 h before
surgery is safe and feasible in the low-risk Japanese sur-
gical population. Physicians are encouraged to use this
practice to maintain the amount of water in the body and
electrolytes and to improve the patient’s comfort.
Keywords Preoperative management  Preoperative
fasting  Oral rehydration therapy  Gastric volume
Introduction
Long preoperative fasting has been a standard practice for
patients undergoing elective surgery to avoid vomiting and
pulmonary aspiration during anesthesia induction. How-
ever, in the 1990s, physicians and scientists in Western
countries started to question whether long preoperative
fasting might be increasing the incidence of dehydration
and perioperative complications. In 1999, the American
Society of Anesthesiologists (ASA) issued a practice
guideline [1] for preoperative fasting in which patients
(except those with delayed gastric emptying) are allowed to
have clear ﬂuids (water, fruit juices without pulp, carbon-
ated beverages, clear tea, and black coffee) until 2 h before
surgery. European anesthesia societies have established
similar guidelines [2–4]. A survey of 258 medical institu-
tions in ﬁve northern European countries revealed that most
of them allowed clear ﬂuids up to a median of 2 h before
surgery [5]. In contrast, a 2003 nationwide survey of pre-
operative fasting in Japanese anesthesia-teaching hospitals
revealed that most hospitals used long preoperative fasting:
the median duration of fasting in adults was 9 h before
morning surgery and 6 h before afternoon surgery [6].
Perioperative ﬂuid and electrolyte balance should be
managed so that patients enter the operating room with
normal ﬂuid and electrolyte balance, instead of starting the
procedure at anesthesia induction [7]. For surgical patients,
recent Japanese studies have shown that oral rehydration
therapy is a safe and effective method for managing pre-
operative water and electrolyte intake [8], but this result
still needs to be conﬁrmed by larger randomized clinical
trials.
Therefore, we conducted a multicenter clinical study to
investigate the safety and efﬁcacy of oral rehydration
therapy until 2 h before surgery by using an oral rehydra-
tion solution (ORS). The objective of our study was to
improve current preoperative fasting practice and to eval-
uate the efﬁcacy of preoperative oral rehydration therapy.
Patients and methods
The study was conducted at six institutions: Tokai Uni-
versity Hospital, Saitama Medical University Saitama
Medical Center, Jichi Medical University Saitama Medical
Center, Nippon Medical School Hospital, Kyorin Univer-
sity Hospital, and Kawasaki Medical School Hospital. The
study was approved by the Institutional Ethics Committee
of each institution and was conducted in accordance with
Declaration of Helsinki-Ethical Principles for Medical
Research Involving Human Subjects and with the Ethical
Guidelines for Clinical Research issued by Ministry of
Health, Labour, and Welfare.
Patients
Patients were eligible for the study if they were between 20
and 80 years old; scheduled to have elective, morning sur-
gery requiring general anesthesia between January 2010 and
March2011;andwereASAphysicalstatusIorII.Exclusion
criteria were dysphagia, esophagostenosis, the inability to
take food orally as a result of neurological and other disor-
ders; gastrointestinal obstruction; renal dysfunction (a cre-
atinine clearance of 20 ml min
-1 or lower or dialysis);
electrolyte abnormalities; body mass index (BMI) of
35 kg m
-2 or larger; and pregnancy. Also excluded were
patients receiving intravenous ﬂuid for any reasons preop-
eratively; a premedication; an H2 receptor blocker or a pro-
tonpumpinhibitor;adiuretic;orsteroids.Patientsotherwise
deemed unsuitable for the study were also excluded.
Experimental plan
Before the study, written informed consents were obtained
after the patients were extensively informed about the study
procedure. The enrolled patients were assigned at random to
either an ORS group or to a fasting group at each institution.
Randomization was performed according to a computer-
generated schedule with a permuted-block design.
Primary endpoints were gastric volume and its pH imme-
diately after anesthesia induction. Secondary endpoints
included the incidence of vomiting and aspiration associated
with anesthesia induction, the relationships of gastric ﬂuid
volume and with age and with BMI in the ORS group, the
effect of rehydration, vital signs, and the patient’s comfort.
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123Patientsinbothgroupswereallowedtohavefoodordrink
until2100onthenightbeforesurgery(Fig. 1).Patientsinthe
ORS groupconsumedup to 1,000 mlof ORS (OS-1; Otsuka
Pharmaceutical Factory, Tokushima, Japan; Table 1):
500 ml between 2100 the night before surgery and the time
theywokeupthenextmorningand500 mlinthemorningof
surgery up until 2 h before surgery. Patients in the fasting
group started fasting at 2100 the night before surgery.
Patients in either group who needed to take medications
orally before surgery were allowed to do so with 20–50 ml
water until 2 h before surgery. Types of surgery, anesthesia
methods, and intraoperative ﬂuid management were at the
discretion of each institution.
Gastric ﬂuid volume and gastric ﬂuid pH of the patients
were measured in supine position immediately after anes-
thesia induction. Any incidences of vomiting or aspiration
were recorded. Patients were intubated by mouth or nose
with a nasogastric tube (the tube was inserted until 60 cm of
the tube was placed inside the body). Correct placement of
thetubeinthestomachwasconﬁrmedbyhearingtheairwith
a stethoscope, and gastric contents were suctioned at 60, 55,
and50 cmfromthetopofthecatheterwithacathetersyringe
[9]. This procedure was repeated three times. Gastric ﬂuid
was sampled by the same person at each institution, when-
ever possible. Gastric ﬂuid pH was measured by SRL (SRL,
Inc., Clinical Laboratory Testing Company, Tokyo, Japan).
We evaluated the efﬁcacy of the ORS to provide hydration
and electrolytes by measuring the fractional excretion of
sodium (FENa), the fractional excretion of urea nitrogen
(FEUN), ratio of serum urea nitrogen to serum creatinine,
hematocrit, serum total protein, serum albumin, serum
electrolytes (sodium, potassium, and chlorine), urine output
(between 2100 the night before surgery and start of surgery
and during surgery), and the amount of vasoconstrictors or
intravenous solutions used during surgery. Blood was taken
immediately after anesthesia induction, and the ﬁrst urine
sample was taken after a urinary catheter was placed.
Patients were asked whether they were thirsty, hungry, or
anxious before they entered the operating room. They were
alsoaskedtwicewhethertheywerenauseousorhadvomited,
on the night after surgery and at noon the next day. Patients
completed the questionnaire form. Vital signs (blood pres-
sure, pulse rate, and body temperature) were measured after
dinnerthenightbeforesurgery;beforeenteringtheoperating
Day before surgery Day of surgery Day after surgery
2h before surgery End of surgery
Patient's sensation
Urine sampling
Urine collection
Fluid, vasopressor dose
Vital signs
Free food intake
Vomiting, aspiration
Fasting
Sampling of gastric fluid
Immediately after
anesthesia induction
Blood sampling
Fasting group
21:00
Oral rehydration solution
1,000 ml Fasting ORS group
Fig. 1 Schedule of treatment
and data collection in the study
that tested the safety and
efﬁcacy of oral rehydration
therapy until 2 h before surgery
under general anesthesia. ORS
group, oral rehydration solution
group (OS-1; oral rehydration
solution: Otsuka Pharmaceutical
Factory, Tokushima, Japan)
Table 1 Composition of the oral rehydration solution (OS-1) used to
test the safety and efﬁcacy of oral rehydration therapy until 2 h before
surgery
Volume (ml) 500
Energy (kcal) 50
Carbohydrate (%) 2.5 (glucose, 1.8)
Electrolytes (mEq l
-1)
Sodium 50
Potassium 20
Magnesium 2
Chloride 50
Lactate 31
Phosphorus (mmol l
-1)2
pH 3.9
Osmolarity (mOsm l
-1) About 270
OS-1, Otsuka Pharmaceutical Factory, Tokushima, Japan
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123room;at5,10, 15,30, and60 min after anestheticinduction;
and every 1 h afterwards. Blood and urine samples were
tested by SRL.
Statistical methods
In this noninferiority study, gastric volumes were com-
pared between the ORS group and the fasting group.
Sample size calculation was based on a Cochrane review of
studies on preoperative fasting and assumed that between-
group difference in the residual gastric volume was 0 ml,
noninferiority margin was ?8 ml, standard deviation of
residual gastric volume was 25 ml, two-tailed signiﬁcance
level was 0.05, and power was 0.80 [10]. The needed
sample size was 122 per group, which was increased to 150
per group to allow for withdrawals.
For the primary endpoint, mean, standard deviation,
maximum, median, minimum, third quartile, and ﬁrst
quartile of the gastric ﬂuid volume and gastric ﬂuid pH
were calculated for each group. For the secondary end-
points, mean standard deviation, maximum, median, min-
imum, third quartile, and ﬁrst quartile of FENa and FEUN
were calculated. For other results, mean and standard
deviation were calculated for each group. The SAS statis-
tical software package, version 9.1.3 (SAS Institute Japan,
Tokyo, Japan), was used for statistical analyses. Differ-
ences were considered statistically signiﬁcant at the 0.05
level for both unpaired t tests and Chi-square test. Differ-
ences in patient demographic characteristics were consid-
ered signiﬁcant at the 0.15 level. Pearson product-moment
correlation coefﬁcient was used for correlation analyses.
Analysis of variance was performed on gastric ﬂuid volume
and gastric ﬂuid pH with institutions and groups used as
factors to check for confounding.
Results
Of 300 patients enrolled, 150 were assigned to the ORS
group and 150 to the fasting group. Of these, 26 withdrew,
leaving 135 in the ORS group and 139 in the fasting group
(Fig. 2). Patients underwent otorhinolaryngological sur-
gery, orthopedic/plastic surgery, gynecological surgery,
breast and thyroid surgery, or thoracic surgery. BMI was
signiﬁcantly different between groups, but the difference
was not clinically important. Other demographic charac-
teristics did not differ signiﬁcantly between groups
(Table 2). Mean (SD) ORS intake in the ORS group was
414 (137) ml the night before surgery and 398 (143) ml on
the morning of surgery.
Mean (SD) gastric ﬂuid volume at anesthesia induction
did not differ signiﬁcantly between groups (P = 0.30): 15.1
(14.0) ml(range, 0–60 ml)inthe ORSgroupand17.5 (23.2)
ml(range,0–155 ml)inthefastinggroup(Fig. 3).Themean
difference between the ORS group and fasting group was -
2.5 ml. The 95% conﬁdence interval ranged from -7.1 to
?2.2 ml and did not include the noninferior limit of ?8 ml.
Mean (SD) gastric ﬂuid pH was 2.1 (1.9) in the ORS group
and 2.2 (2.0) in the fasting group; there was no signiﬁcant
difference between groups (P = 0.59; Table 3). Analysis of
variance revealed no confounding between institutions and
groups on gastric ﬂuid volume or gastric ﬂuid pH (data not
reported). No incidence of vomiting or aspiration was
reported. A statistically signiﬁcant but clinically unimpor-
tant inverse relationship was seen between age and gastric
ﬂuid volume in the ORS group (R
2 = 0.0809, P = 0.001);
theolderthepatient,thesmallerthegastricﬂuidvolumewas
to become. There was no correlation between the BMI and
gastric ﬂuid volume (R
2 = 0.0003, P = 0.85).
In the ORS group, mean FENa and FEUN immediately
after anesthesia induction were both signiﬁcantly greater
than those in the fasting group (P\0.001 for both vari-
ables): mean (SD) FENa was 0.94% (0.45%) in the ORS
group, 0.64% (0.41%) in the fasting group, and mean (SD)
FEUN was 33.7% (8.2%) in the ORS group and 27.2%
(9.2%) in the fasting group (Fig. 4). The mean (SD) ratio of
serum urea nitrogen to serum creatinine was signiﬁcantly
(P\0.01) smaller in the ORS group [17.9 (4.9)] than in
the fasting group [19.7 (5.2)]. The urine output between the
night before surgery and start of surgery and up to 1 h after
surgery was signiﬁcantly greater in the ORS group
(P\0.001, 0.01). None of the physiological characteris-
tics or vital signs differed between groups (Table 3). Both
ORS
group
(n=150)
Fasting
group
(n=150)
Received
intervention
(n=135)
Withdrew consent
(n=8), cancelled
operation (n=5),
administered steroid
(n=2)
Withdrew consent
(n=9), administered
steroid (n=1)
Assessed for eligibility
(n=300)
Analyzed
(n=139)
Analyzed
(n=135)
Drank water (n=1)
Rondomized
(n=300)
Received
intervention
(n=140)
Fig. 2 Flow diagram of the study progress and disposition of 300
patients enrolled in the study that tested the safety and efﬁcacy of oral
rehydration therapy until 2 h before surgery
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cantly fewer patients in the ORS group (P\0.001, 0.01),
although the proportion of those reporting perioperative
anxiety, nausea, and vomiting did not differ signiﬁcantly
between groups (Table 4).
Discussion
In the present study, gastric ﬂuid volume in the ORS group
was not inferior to that in the fasting group. Others have
reported that gastric ﬂuid volume was smaller in patients
Table 2 Demographic and
system organ class of patients in
a study testing the safety and
efﬁcacy of oral rehydration
therapy until 2 h before surgery
ASA American Society of
Anesthesiologists, ORS oral
rehydration solution
a Chi-square test, a = 0.15
b Unpaired t test, a = 0.15
ORS group Fasting group P
Sex, men/women 36/99 39/100 NS
a
Age, mean (SD) (years) 47.9 (13.5) 48.6 (14.9) NS
b
Body mass index, mean (SD) (kg m
-2) 22.5 (3.1) 23.1 (4.0) 0.14
b
ASA physical status (n)N S
a
I8 8 9 1
II 47 48
System organ class (n)N S
a
Neoplasms benign, malignant, and unspeciﬁed 90 91
Infections and infestations 14 11
Musculoskeletal and connective tissue disorders 10 13
Reproductive system and breast disorders 6 4
Injury, poisoning, and procedural complications 4 8
Surgical and medical procedures 3 5
Respiratory, thoracic, and mediastinal disorders 2 4
Endocrine disorders 2 2
Gastrointestinal disorders 2 0
Nervous system disorders 1 1
Skin and subcutaneous tissue disorders 1 0
Duration of surgery, mean (SD) (min) 155.3 (113.0) 152.5 (99.9) NS
b
Duration of anesthesia, mean (SD) (min) 213.7 (120.2) 212.1 (105.2) NS
b
Intraoperative blood loss, mean (SD) (ml) 366.8 (751.0) 295.8 (379.3) NS
b
Gastric fluid volume Gastric fluid pH
ORS
group
n=130
Fasting 
group
n=135
ORS
group
n=121
Fasting 
group
n=123
P=0.30 P=0.59
ml
Mean SD
Maximum
Top quartile
Median
Bottom quartile
Minimum
50
100
150
200
2
4
6
8
10
0 0
Fig. 3 Gastric ﬂuid volume and
gastric ﬂuid pH immediately
after anesthesia induction in
patients who received an oral
rehydration solution and those
who fasted overnight. (Plots
show medians, ranges, and
interquartile ranges.) Statistical
analysis: unpaired t test
(a = 0.05)
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was in fasting patients, and our study results showed the
same trends [10]. If the gastric ﬂuid volume is 200 ml or
larger when anesthesia is induced, the patient is at increased
risk for vomiting and aspiration [2]. However, no patient
had a gastric volume greater than 200 ml: the maximum
volume was 60 ml in the ORS group and 155 ml in the
fasting group. Gastric ﬂuid pH did not differ signiﬁcantly
between the groups. Thus, oral rehydration therapy is fea-
sible with sufﬁcient safety margin for up to 2 h before
surgery. Perioperative fasting guidelines in adults and
children issued by the European Society of Anaesthesiology
state that patients can safely drink carbohydrate-rich ﬂuids
up to 2 h before surgery. However, the evidence for safety
Table 3 Physiological
characteristics of patients in a
study testing the safety and
efﬁcacy of oral rehydration
therapy until 2 h before surgery
a Measurements taken
immediately before anesthesia
induction unless otherwise
indicated
b Unpaired t test, a = 0.05
Characteristic
a ORS group Fasting group P
b
Blood urea nitrogen/serum creatinine ratio, mean (SD) 17.9 (4.9) 19.7 (5.2) \0.01
Hematocrit, mean (SD) (%) 40.2 (4.9) 40.4 (5.0) NS
Serum total protein, mean (SD) (g dl
-1) 7.0 (0.6) 7.0 (0.7) NS
Serum albumin, mean (SD) (g dl
-1) 4.2 (0.5) 4.1 (0.5) NS
Serum sodium, mean (SD) (mEq l
-1) 140.5 (1.8) 140.5 (1.9) NS
Serum potassium, mean (SD) (mEq l
-1) 4.1 (0.3) 4.1 (0.3) NS
Serum chloride, mean (SD) (mEq l
-1) 105.6 (1.8) 105.6 (2.1) NS
Urine volume, mean (SD) (ml kg
-1)
Between night before surgery and start of surgery 15.3 (8.2) 10.6 (5.4) \0.001
Between start of surgery and 1 h later 2.1 (2.3) 1.4 (1.8) \0.01
Between 1 and 2 h later 3.2 (3.8) 2.8 (3.7) NS
Between 2 and 3 h later 3.7 (4.3) 2.8 (3.6) NS
Between 3 and 4 h later 3.1 (4.6) 2.4 (2.0) NS
Dose of vasopressor during surgery
Ephedrine hydrochloride, mean (SD) (mg) 12.5 (9.5) 11.0 (8.6) NS
Phenylephrine hydrochloride, mean (SD) (mg) 0.3 (0.3) 0.4 (0.2) NS
Volume of ﬂuid during surgery
Crystalloid solution, mean (SD) (ml kg
-1 h
-1) 9.0 (3.6) 8.9 (3.6) NS
Colloid solution, mean (SD) (ml kg
-1 h
-1) 0.8 (1.5) 0.8 (1.5) NS
Mean SD
Maximum
Top quartile
Median
Bottom quartile
Minimum
ORS
group
n=134
Fasting 
group
n=135
ORS
group
n=134
Fasting 
group
n=135
FENa FEUN
P <0.001
P <0.001
0
1.0
2.0
3.0
%
0
20
40
60
80
100
%
Fig. 4 Fractional excretion of
sodium (FENa) and fractional
excretion of urea nitrogen
(FEUN) immediately after
anesthesia induction in patients
who received an oral
rehydration solution and those
who fasted overnight. (Plots
show medians, ranges, and
interquartile ranges.) Statistical
analysis: unpaired t test
a = 0.05). FENa = (urine
sodium 9 serum creatinine)/
(serum sodium 9urine
creatinine), FEUN = (urine
urea nitrogen 9 serum
creatinine)/(blood urea
nitrogen 9 urine creatinine)
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for perioperative use (predominantly maltodextrins); not all
carbohydrates are necessarily safe [4]. We also believe
beverages with clearly established evidence of safety
should be given to patients undergoing surgery.
We excluded patients aged 80 years or older, severely
obese patients (BMI C 35 kg m
-2), and pregnant women.
However, gastric ﬂuid volume was slightly inversely rela-
ted to age in the ORS group, and gastric ﬂuid volume was
not related to BMI. In studies with elderly patients, clear
ﬂuids intake until 2 h before surgery did not cause prob-
lems [11, 12]. In studies with obese patients
(BMI[30 kg m
-2), the gastric ﬂuid volume in patients
who received clear ﬂuids until 2 h before surgery was
similar to that in fasting patients [13]. A study of obese
pregnant women showed that the gastric ﬂuid volume 1 h
after they drank 300 ml water was the same as the volume
when fasting before drinking water [14]. Practice Guide-
lines for Obstetric Anesthesia issued by the ASA also state
that patients can safely receive clear ﬂuids until 2 h before
surgery, except those who at increased risk for operative
delivery, such as a non-reassuring fetal heart rate pattern
[15]. Therefore, it seems reasonable that oral rehydration
therapy can be safely administered to elderly, obese, or
pregnant patients up to 2 h before surgery.
Both FENa and FEUN, which we used to evaluate the
adequacy of hydration and electrolytes provided by the
ORS, indicate the percentages of sodium and urea nitrogen
that are ﬁltrated through the glomerulus and ultimately
excreted to the urine; that is, they are used as an index for
renal blood ﬂow [16, 17]. Both parameters decrease in
dehydrated patients with normal renal function. (We
excluded patients with a creatinine clearance of
20 ml min
-1 or less or those on dialysis.) Our results
revealed both FENa and FEUN in the fasting group were
signiﬁcantly lower than those in the ORS group. Also, the
ratio of serum urea nitrogen to serum creatinine was sig-
niﬁcantly higher, and urine output before surgery and
during the ﬁrst hour of surgery were signiﬁcantly lower in
the fasting group. Furthermore, before surgery, 65.0% in
the fasting group reported being thirsty. Thus, fasting
starting on the night before surgery can result in a
decreased amount of water in the body, and the decrease
would have been prevented with oral rehydration therapy.
The amount of vasoconstrictors or intravenous solutions
used during surgery did not differ signiﬁcantly between
groups. The following mechanisms can be proposed: there
were many confounding factors including the type of sur-
gery, methods of anesthesia, and type and administration
rate of intravenous ﬂuids. Although FENa, FEUN, and
serum biochemical proﬁles suggested the positive effects
of ORS, actual effect on the amount of water in the body
could have been minimal.
In our study, the only apparent clinical advantages were
that patients in the ORS group reported being less thirsty
and hungry. However, patient comfort is among the
important clinical indices in the era of fast-track surgery.
The mean (SD) ORS intake between the night before sur-
gery and 2 h before surgery was 812 (240) ml, which was
larger than expected and indicates the ORS is well toler-
ated. Also, there were few incidences of nausea or vomit-
ing associated with ORS intake after surgery.
The safety and efﬁcacy of the ORS for mildly to mod-
erately dehydrated patients have already been studied [18–
20]. Our study provided further supporting data regarding
the safety and efﬁcacy of the ORS in preoperative patients.
Limitations of the study
We did not include high-risk patients, patients with ASA
physicalstatusIIIorhigher,andthesafetyandefﬁcacyofthe
ORS in these patients are still unknown. Also, the effects of
the supplemental electrolytes and glucose cannot be differ-
entiated from those of rehydration. Therefore, to further
investigatethetruebeneﬁtsoforalrehydrationwiththeORS,
another study should be undertaken with water as a control
arm under the speciﬁed type of surgery and methods of
anesthesia and intravenous administration maintenance.
Conclusions
We investigated the safety and efﬁcacy of oral rehydration
therapy until 2 h before surgery in a multicenter
Table 4 Sensations reported at key times by patients in a study
testing the safety and efﬁcacy of oral rehydration therapy until 2 h
before surgery
Sensation ORS group Fasting group P
a
Before entering the operating room
Dry mouth, yes/no/
difﬁcult to
answer (%)
11.9/83.0/5.2 65.0/28.5/6.6 \0.001
Hunger, yes/no/
difﬁcult to
answer (%)
32.6/56.3/11.1 52.6/35.8/11.7 \0.01
Anxiety, yes/no/
difﬁcult to
answer (%)
42.5/43.3/14.2 48.9/37.2/13.9 NS
Night on the day of surgery
Nausea, yes/no (%) 27.8/72.2 24.6/75.4 NS
Vomiting, yes/no (%) 17.3/82.7 14.2/85.8 NS
Afternoon on the day after surgery
Nausea, yes/no (%) 15.3/84.7 20.3/79.7 NS
Vomiting, yes/no (%) 9.2/90.8 14.2/85.8 NS
a Chi-square test, a = 0.05
26 J Anesth (2012) 26:20–27
123randomized controlled clinical study. Gastric volume in the
ORS group immediately after anesthesia induction was not
inferior to that in the fasting group, and no signiﬁcant
difference in pH was found between groups. Our study
supports that oral rehydration therapy until 2 h before
surgery is safe. Thus, healthcare professionals should also
be encouraged to use oral rehydration therapy until 2 h
before surgery to maintain the amount of water in the body
and electrolytes and to improve the patient’s comfort.
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